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Reduced Oxazolone-Induced Skin Inflammation in
MAPKAP Kinase 2 Knockout Mice
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and Lars Iversen1
Mitogen-activated protein kinase (MAPK) AP kinase 2 (MK2) is a serine/threonine kinase that is phosphorylated
and activated by p38 MAPK. MK2 regulates the expression of various proinflammatory cytokines including
TNF-a, IL-1b, IL-6, and IL-8. Recently, MK2 was demonstrated to be activated in lesional psoriatic epidermis. This
study investigates for the first time the role of MK2 in skin inflammation using the model of oxazolone-induced
acute allergic contact dermatitis in mice. We show that oxazolone treatment leads to increased expression and
sustained activation of both p38 MAPK and MK2. The inflammatory response was determined by ear thickness,
myeloperoxidase activity, and histology after oxazolone challenge. Pretreatment with the p38 MAPK inhibitor
SB202190 and genetic ablation of MK2 inhibit this inflammatory response. In particular, IL-1b and, to a smaller but
significant extent, also TNF-a and IFN-g expression were decreased in MK2 knockout mice compared with wild-type
mice. These results indicate that MK2 is a potential target for the treatment of inflammatory skin diseases.
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INTRODUCTION
p38 mitogen-activated protein kinase (MAPK) activity is
critical for normal immune and inflammatory responses
(Roux and Blenis, 2004). The expression of many cytokines,
transcription factors, and cell-surface receptors has been
demonstrated to be regulated by p38 MAPK (Ono and Han,
2000).
Mitogen-activated protein kinase (MAPK) AP kinase 2
(MK2) is a downstream target of the p38 MAPK that
is phosphorylated predominately by the p38a isoform
(Kotlyarov et al., 2002; Beardmore et al., 2005; Gaestel,
2006). Deletion of MK2 by homologous recombination in
mouse has demonstrated MK2 to be involved in the
posttranscriptional regulation of various cytokines including
TNF-a, IL-6, and IL-8 (Kotlyarov et al., 2002; Neininger et al.,
2002; Campbell et al., 2004). MK2-deficient mouse spleen
cells showed a pronounced reduction in the biosynthesis of
various proinflammatory cytokines and in LPS-induced
endotoxic shock a more than 90% reduction in serum levels
of TNF-a was observed (Kotlyarov et al., 1999). In addition, a
significant resistance to collagen-induced arthritis was
demonstrated in MK2 knockout mice, indicating a crucial
role of MK2 in the development of chronic inflammation
in vivo (Hegen et al., 2006). Taken together, these studies
indicate a pivotal role of MK2 in inflammatory responses.
CD4þ Th cells play a major role during immune
responses and in the pathogenesis of several inflammatory
skin disorders. The Th1 subset is typically described as a
producer of IFN-g and IL-2, whereas the Th2 subset is known
as a producer of IL-4, IL-5, and IL-13 (Romagnani, 1997).
Among inflammatory skin diseases, psoriasis is often referred
to as a Th1-dependent skin inflammation, whereas atopic
dermatitis is considered as Th2-dominated disease (Bos et al.,
2005; Krueger and Ellis, 2005).
Several publications have associated p38 MAPK activation
to skin inflammation (Takanami-Ohnishi et al., 2002;
Johansen et al., 2005), whereas MK2 has been only
investigated in psoriasis (Johansen et al., 2006). MK2 was
suggested to regulate TNF-a expression in lesional psoriatic
skin at a posttranscriptional level (Johansen et al., 2006).
Interestingly, anti-TNF-a therapies have proved effective in
treating psoriasis, demonstrating a critical role of this
cytokine in the disease pathogenesis. MK2 has, therefore,
been suggested as a potential target in the treatment of
inflammatory skin diseases (Arthur and Darragh, 2006).
Several mouse models have been established to study skin
inflammation (Gudjonsson et al., 2007). The group of
transgenic mice that spontaneously develop skin inflamma-
tion include transgenic-a/b-integrin, -K14/VEGF, -Tie2,
-TGFb-1, -IL-20, -K5. Stat3C mice, -IL-1-receptor antagonist,
and epidermal JUN protein-deficient mice (Petersen, 2006).
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Other inflammation models include the xenograft mouse
model of psoriasis in severe combined immunodeficiency
disease mice (Nickoloff et al., 1995) and the delayed allergy
reactions (Petersen, 2006). These models have been used in
primary drug discovery in relation to inflammatory skin
diseases (Petersen, 2006). The acute allergy response to
oxazolone exhibits primarily a Th1 response (Dearman et al.,
1994; Webb et al., 1998) that is characterized by infiltration
of neutrophils and expression of TNF-a and IFN-g (Webb
et al., 1998).
To assess the role of MK2 in skin inflammation, we
compared the degree of inflammation in MK2 knockout mice
with wild-type mice in the acute oxazolone-induced allergic
contact dermatitis model. We demonstrated that the inflam-
matory response to oxazolone is significantly decreased in
MK2 knockout mice, as determined by changes of ear
thickness and the degree of neutrophil infiltration in the skin.
In addition, we demonstrated that the expression of TNF-a,
IL-1b, and IFN-g protein was regulated by MK2 in this mouse
model. Our results suggest a significant role of MK2 in the
development of skin inflammation and in the induction of
Th1 responses.
RESULTS
Oxazolone-induced skin inflammation leads to sustained
activation of p38 MAPK and MK2
To characterize the acute allergic oxazolone model, different
challenge concentrations of oxazolone were used. On day 1,
all mice were sensitized with 1.5% oxazolone at the
abdomen, and on day 7, the ears of the mice were challenged
with oxazolone. Thickness of intact ears was measured at
various time points after challenge (Figure 1a). A significant
increase (Po0.0001) in ear thickness was seen 24, 48, and
72 hours post-challenge with 0.5 and 1.5% oxazolone but not
with 0.1% oxazolone (Figure 1a). To investigate a possible
toxic effect in this model, the same experiment was carried
out without sensitization. Without previous sensitization, ear
thickness at 24, 48, and 72 hours after application of 0.5%
oxazolone was significantly (all P-values o0.01) lower than
after application of 1.5% oxazolone and very close to the
values for 0.1% oxazolone (Figure 1b), a concentration that
does not show a significant effect (Figure 1a). To minimize
the toxic effects in this model, subsequent experiments were
performed using a challenge concentration of 0.5% oxazo-
lone.
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Figure 1. Characterization of the acute oxazolone-induced allergic contact dermatitis model in wild-type mice. (a) On day 1, all mice were sensitized with
1.5% oxazolone on the abdomen. On day 7, the ears of the mice were challenged with 0.1, 0.5, or 1.5% oxazolone. The ear thickness of intact ears was
measured using a Mitutyo digimatic indicator at 0, 24, 48, and 72 hours. (b) The same experiment was carried out without sensitization. Groups of four mice
were compared in both (a, b). Results are shown as back-transformed means with 95% confidence intervals. Significant differences are marked *Po0.0001
(compared with ear thickness at 0 hour); **Po0.01 (compared with 1.5% oxazolone for the indicated times). In figure (c) and (d), a challenge concentration of
0.5% oxazolone was used. (c) Whole-cell protein extracts were prepared from the mice ears and analyzed by western blotting. The proteins were separated on
an 8–16% gradient gel and blotted onto a nitrocellulose membrane. After blotting, the membrane was probed with the indicated antibodies. Equal loading was
confirmed by incubation with an anti-b-actin-antibody. (d) Whole-protein extracts (200 mg of protein) from the mice ears were prepared for immunoprecipitation
of p38 MAPK. Enzyme activities were determined by an in vitro kinase assay, using ATF2 as the substrate. Kinase reactions were prepared for SDS-PAGE, and
ATF2 phosphorylation was detected by western blotting using an anti-phospho-ATF2 antibody. Representative results of four (c) and three (d) separate
experiments are shown.
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Modulation of p38 MAPK signal transduction pathway has
not been investigated in the oxazolone-induced acute allergic
contact dermatitis model before. We, therefore, analyzed ear
biopsies at different time points by western blotting using
antibodies specific for regulatory phosphorylation sites of p38
and MK2 to determine whether the p38 MAPK-MK2 signaling
pathway is activated in this model. Using the antibody
recognizing the phosphorylated form of p38 MAPK, we
demonstrated an increase in phosphorylation of p38 MAPK at
5, 8, and 24 hours after oxazolone challenge. The total
protein level of p38 MAPK showed no alterations during
oxazolone challenge (Figure 1c). The phosphorylated forms
of MK2 showed an increase at 8, 24, and 48 hours after
application of oxazolone, and the total protein level of MK2
showed a continuous increase over the 48 hours (Figure 1c).
The increased level of phosphorylated p38 MAPK at 5, 8, and
24 hours post-challenge to oxazolone was paralleled by an
increased kinase activity of p38 MAPK, as measured by
activating transcription factor 2 (ATF2) phosphorylation
induced by immunoprecipitated p38 MAPK in a kinase assay
(Figure 1d).
Pretreatment with the p38-MAPK inhibitor SB202190 reduces
the oxazolone-induced skin inflammatory response in wild-type
mice
To examine the role of p38 MAPK in the inflammatory
response in the acute oxazolone-induced allergic contact
dermatitis model, three groups of mice were sensitized with
1.5% oxazolone on day 1. In group one, the ears of the mice
were pretreated with vehicle 30minutes before they were
challenged with 0.5% of oxazolone on day 7 (Figure 2). In
group two, the ears of the mice were pretreated with
SB202190 (1mg per ear) 30minutes before challenge with
0.5% oxazolone. In group three, the ears of the mice were
pretreated with vehicle 30minutes before they were chal-
lenged with vehicle (Figure 2). Thickness of intact ears was
measured. A significant increase (all P-values o0.0001) in
ear thickness was seen at 24, 48, and 72 hours in the
vehicle pretreated, 0.5% oxazolone-challenged mice. Inter-
estingly, a significant reduction (all P-values o0.001) in
ear thickness was seen at 24, 48, and 72 hours in the
SB202190 pretreated mice compared with the vehicle-
pretreated mice. No significant alterations in ear thickness
were seen in any of the three groups at the beginning of the
experiment (0 hour).
MK2 knockout mice show reduced inflammatory response
compared with wild-type mice in the oxazolone-induced skin
inflammation
To explore the pathophysiological role of MK2 in acute
oxazolone-induced skin inflammation, MK2 knockout mice
and wild-type mice were compared in the experimental
setting described above. A significant reduction (all P-values
o0.01) in ear thickness was observed at 24, 48, and 72 hours
in the MK2 knockout mice compared with wild-type mice
(Figure 3a). No significant difference in ear thickness was
seen in the two groups of mice at the beginning of the
challenge (0 hour).
Neutrophil infiltration in the inflamed skin can be used to
grade the inflammatory response. To determine the degree of
neutrophil infiltration in the ear skin within the two groups of
mice, 4mm punch biopsies were taken 24 hour after
challenge and myeloperoxidase (MPO) activity was assayed.
Compared with wild-type mice, there was a mean 55%
decrease in MPO activity in the MK2 knockout mice
(P¼0.0022) (Figure 3b).
In a separate experiment, biopsies were taken from vehicle
and 0.5% oxazolone-treated wild-type and MK2 knockout
mice 24 hour after challenge. As assessed by histology, the
oxazolone-treated mice had an increased dermal inflamma-
tory infiltrate and edema compared with the vehicle-treated
mice in both wild-type mice and MK2 knockout mice (Figure
3c). However, oxazolone-treated MK2 knockout mice
showed less edema and inflammatory cell infiltration than
oxazolone-treated wild-type mice (Figure 3c).
Oxazolone-induced TNF-a, IL-1b, and IFN-c protein expression
and IL-1b mRNA expression in MK2 knockout mice compared
with wild-type mice
To characterize the cytokines involved in the inflammatory
response, TNF-a, IL-1b, and IFN-g protein levels in MK2
knockout mice and wild-type mice were analyzed in mice
sensitized with 1.5% oxazolone and challenged with 0.5%
oxazolone. In the wild-type mice, there was a weak induction
of TNF-a protein expression (P¼0.035) 4 hours after
oxazolone challenge. However, in MK2 knockout mice, the
TNF-a protein expression level 4 hours post-challenge was
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Figure 2. SB202190 inhibits acute oxazolone-induced allergic contact
dermatitis in wild-type mice. On day 1, three groups of wild-type mice were
sensitized with 1.5% oxazolone on the abdomen. On day 7, the ear thickness
of intact ears was measured in all groups. In group one (n¼ 9), the ears were
pretreated with vehicle 30minutes before they were challenged with 0.5% of
oxazolone. In group two (n¼ 8), the ears of the mice were pretreated with
SB202190 (1mg per ear) 30minutes before challenge with oxazolone. In
group three (n¼4), the ears were pretreated with vehicle 30minutes before
they were challenged with vehicle. Results are shown as back-transformed
means with 95% confidence intervals. Significant differences are marked
*Po0.0001 (compared with ear thickness at 0 hour); **Po0.001 (compared
with 0.5% oxazolone-treated mice at the indicated times).
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significantly reduced (Po0.0001), and the TNF-a protein
expression level in the oxazolone-treated MK2 knockout
mice was similar to the level in the vehicle-treated MK2
knockout mice (P¼ 0.43; Figure 4a), demonstrating that there
was no induction in TNF-a protein expression after oxazo-
lone challenge in the MK2 knockout mice. TNF-a protein
expression was also investigated at 12 and 24 hours but no
significant induction was seen here (data not shown). In
contrast, the IL-1b protein expression level increased
significantly (Po0.0001) 24 hours after challenge with 0.5%
oxazolone in wild-type mice. A nearly 20-fold induction in
IL-1b protein expression level was seen in 0.5% oxazolone-
challenged wild-type mice compared with vehicle-
challenged wild-type mice after 24 hours (Figure 4b). A
comparison of the IL-1b protein expression level 24 hours
post-challenge showed a 65% mean reduction in the MK2
knockout mice compared with wild-type mice (Figure 4b).
The oxazolone-induced IFN-g protein expression level was
significant (P¼ 0.0027), although rather weak at 24 hours in
the wild-type mice. Interestingly, IFN-g protein expression
level 24 hours post-challenge, showed a significant reduction
(P¼0.0081) in the MK2 knockout mice compared with wild-
type mice. Similar to the TNF-a protein expression level, the
IFN-g protein expression level in the oxazolone-treated MK2
knockout mice was not different from vehicle-treated MK2
knockout mice (Figure 4c). Quantitative RT-PCR analysis was
performed to investigate whether the decreased IL-1b protein
level in MK2 knockout mice compared with wild-type mice
was paralleled by a similar decrease in mRNA expression
level. IL-1b mRNA expression after oxazolone showed a
significant (P¼ 0.0086) reduction in the MK2 knockout mice
compared with wild-type mice (Figure 4d).
DISCUSSION
In this study, we employed the oxazolone-induced acute
allergic contact dermatitis mouse model to elucidate the role
of MK2 in skin inflammation. On the basis of these
experiments, we present three previously unreported findings
regarding the role of the p38 MAPK/MK2-signaling pathway
in skin inflammation. First, we demonstrate that p38 MAPK
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Figure 3. MK2 knockout mice show increased resistance to acute oxazolone-induced allergic contact dermatitis. (a) On day 1, MK2 knockout mice and wild-
type (WT) mice were sensitized with 1.5% oxazolone on the abdomen. On day 7, the ears of the mice were challenged with 0.5% oxazolone for the indicated
time points. The ear thickness of intact ears was measured using a Mitutyo digimatic indicator at the indicated time points. Groups of eight mice were compared.
Results are shown as back-transformed means with 95% confidence intervals. Significant differences are marked *Po0.0001 (compared with ear thickness at
0 hour) **Po0.01 (compared with WT at the indicated times). (b) On day 1, WT and MK2 knockout mice were sensitized with 1.5% oxazolone on the abdomen.
On day 7, the ears were challenged with vehicle or with 0.5% oxazolone for 24 hours. Fold MPO activity (arbitrary units (a.u.)) is shown (n¼ 6 for WT (vehicle);
n¼ 16 for WT (0.5% oxazolone); n¼ 15 for MK2 knockout (0.5% oxazolone)). Results are shown as back-transformed means with 95% confidence intervals.
Significant differences are marked *Po0.01 (compared with WT (0.5% oxazolone)). (c) Hematoxylin and eosin-stained histological sections of vehicle-treated
(upper panels, bar¼ 100 mm) and 0.5% oxazolone-treated (lower panels, bar¼ 100mm) WT (left panels) and MK2 knockout mice (right panel) are shown.
Representative sections of whole-mice ears (with two epidermal areas) are shown of an experiment with n¼ 3 for vehicle-treated and n¼9 for 0.5% oxazolone-
treated ears (for both WT and MK2 knockout mice).
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and MK2 are activated in during oxazolone-induced skin
inflammation. Second, we demonstrate that the inflammatory
response to oxazolone is blocked by a p38 MAPK inhibitor
and is significantly decreased in the MK2 knockout mice
indicating a causal involvement of the p38/MK2 axis. Third,
we demonstrate oxazolone-induced IL-1b and partially also
IFN-g and TNF-a, expression in the skin to be dependent on
MK2.
The p38 MAPK pathway has been demonstrated to be
involved in a set of inflammatory diseases including the
inflammatory skin disease psoriasis (Tortarolo et al., 2003;
Johansen et al., 2005; Westra and Limburg, 2006). In
addition, this pathway has been suggested to play an essential
role in contact hypersensitivity (Takanami-Ohnishi et al.,
2002) and the widely distributed contact hapten, nickel, has
been shown to activate the p38 MAPK pathway (Goebeler
et al., 2001).
The activation of the p38 MAPK pathway in the
oxazolone-induced acute allergic contact dermatitis model
has never been assessed before. It is therefore interesting that
the p38 MAPK and the MK2 signaling pathways show
sustained activation in this model. In addition, we demon-
strate that the inflammatory response in the oxazolone-
induced acute allergic contact dermatitis model can be
inhibited by topical pretreatment with the p38 MAPK
inhibitor, SB202190. Previously, p38 MAPK inhibition with
SB202190 has been shown to protect against the acute
damaging effects of ultraviolet irradiation (Hildesheim et al.,
2004) that is also consistent with studies in SKH-1 hairless
mice where UVB irradiation lead to a time-dependent
phosphorylation of epidermal p38 MAPK and MK2 (Kim
et al., 2005). In another study, SB202190 significantly
inhibited ear swelling in mice and cytokine levels in a
hypersensitivity model using 2,4-dinitro-1-fluorobenzene
(Takanami-Ohnishi et al., 2002). These studies demonstrate
that activation of the p38 MAPK signaling pathway is
important in the pathogenesis of inflammatory skin diseases.
Because the inflammatory response in the oxazolone-
induced acute allergic contact dermatitis model is also
regulated through the p38 MAPK signaling pathway, this
50
45
40
35
30
25
20
15
10
5
0
2,500
2,000
1500
1,000
500
3,000
0
TN
F-
α
 
pg
 p
er
 m
g 
pr
ot
ei
n
TNF-α
IL
-1
β p
g 
pe
r m
g 
pr
ot
ei
n
WT
MK2–/–
IL-1βWTMK2–/–
∗
∗∗
#
##
14
12
10
8
6
4
2
0
0.06
0.05
0.04
0.03
0.02
0.01
0
IL
-1
β m
R
N
A 
no
rm
a
liz
e
d 
to
 G
AP
DH
IF
N
-γ
 
pg
 p
er
 m
g 
pr
ot
ei
n
IL-1β mRNAWTMK2–/–
IFN-γWTMK2–/–
¤
¤¤
Vehicle
Vehicle
0.5% OXazolone
0.5% OXazolone
Figure 4. Oxazolone-induced TNF-a, IL-1b, and IFN-c protein expression
levels and IL-1b mRNA expression level in MK2 knockout mice. On day 1,
MK2 knockout mice and wild-type (WT) mice were sensitized with 1.5%
oxazolone on the abdomen. On day 7, the ears of the mice were challenged
with 0.5% oxazolone or vehicle. (a) TNF-a protein expression was
determined at 4 hours after challenge with 0.5% oxazolone (WT, n¼ 12;
MK2/, n¼ 9) or vehicle (WT, n¼4; MK2/, n¼ 3). (b) and (c) IL-1b and
IFN-g protein expression levels were determined at 24 hours stimulation with
0.5% oxazolone (WT, n¼ 16; MK2/, n¼ 12) or vehicle (WT, n¼4; MK2/,
n¼ 4). (d) The IL-1b mRNA expression was analyzed by quantitative RT-PCR
and normalized to GAPDH. Punch biopsies (4mm) were obtained from WT,
vehicle treated (n¼ 3); MK2 knockout, vehicle treated (n¼ 2); WT, oxazolone
treated (n¼ 12) and MK2 knockout, oxazolone treated (n¼ 10) 6 hours post-
challenge. Results are shown as back-transformed means with 95%
confidence intervals. *P¼0.035 (compared with WT, vehicle); **Po0.0001
(compared with WT, 0.5% oxazolone); #Po0.0001 (compared with WT,
vehicle); ##Po0.0001 (compared with WT, 0.5% oxazolone);&, P¼0.0027
(compared with WT, vehicle); &&, P¼ 0.0081 (compared with WT, 0.5%
oxazolone); ’, Po0.0001 (compared with WT, vehicle); ’’, P¼0.0086
(compared with WT, 0.5% oxazolone).
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mouse model should be adequate for studying the pathogenic
mechanisms in skin inflammation.
The role of MK2 in inflammatory conditions is not as well
characterized as the role of p38 MAPK. MK2 has been shown
to play a pivotal role in the pathogenesis of arthritis using the
murine model of collagen-induced arthritis in MK2 knockout
mice (Hegen et al., 2006). There, it was demonstrated that
MK2 knockout mice exhibit reduced severity and incidences
of collagen-induced arthritis compared with wild-type mice
(Hegen et al., 2006). In inflammatory skin conditions, MK2
has only been investigated in psoriasis. MK2 was shown to be
activated in lesional psoriatic epidermis and MK2 was
suggested to regulate TNF-a expression at a posttranscrip-
tional level in psoriatic skin (Johansen et al., 2006).
Here, we showed that the inflammatory response, as
determined by increase in ear thickness and MPO activity,
was significantly reduced in MK2-deficient mice compared
with wild-type mice. In accordance with that, the histological
examination revealed less dermal inflammatory infiltration
and edema in the oxazolone-treated MK2-deficient mice
compared with the oxazolone-treated wild-type mice. This
demonstrates MK2 as a key kinase in oxazolone-induced
acute contact dermatitis.
Proinflammatory cytokines, such as TNF-a, IL-1b, IL-6
(Kimber et al., 2000; Westphal et al., 2003), and possibly
IFN-g (Webb et al., 1998), are likely to play a crucial role in
allergic contact dermatitis and also in other inflammatory
skin conditions. IL-1b has been demonstrated to be upregu-
lated in the epidermis after challenge with allergens (Enk and
Katz, 1995) and a high TNF-a level has been detected in
patients with zinc allergic contact dermatitis compared with
healthy controls (Yanagi et al., 2006). Furthermore, TNF-a
has previously been shown to be upregulated in the
oxazolone-induced acute allergic contact dermatitis model
with significant increases at 4 hours, and IFN-g with
significant increases at 24 hours (Webb et al., 1998). There-
fore, cytokine protein expression levels were studied at these
time points in this study. We found a consistently although
weak induction of both TNF-a and IFN-g protein expression
levels after oxazolone challenge. Furthermore, a very strong
induction of IL-1b protein expression was seen after
oxazolone challenge. MK2 knockout mice showed a
pronounced reduction in TNF-a, IL-1b, and IFN-g protein
expression levels compared with wild-type mice after
oxazolone challenge. In accordance with our results, TNF-
a, IL-1b, and IFN-g expression levels have been previously
described to be regulated by a MK2-dependent mechanism.
Cells derived from MK2-deficient mice showed reduced
levels of lipopolysaccharide-induced synthesis of several
cytokines including IL-1b, IL-6, TNF-a, and IFN-g (Kotlyarov
et al., 1999). IL-1b mRNA expression level was studied at
6 hours. In accordance with previous results (Kotlyarov et al.,
1999), the IL-1b mRNA expression level was also signifi-
cantly reduced in this skin inflammation model in MK2
knockout mice compared with wild-type mice.
The oxazolone-induced acute allergic contact dermatitis
mouse model used in this study is a simple but well-
characterized skin inflammatory model. It represents an
allergic contact dermatitis model with a Th1-dependent
response. By using this model, we were able to characterize
the role of MK2 in the regulation of inflammatory responses
in the skin. MK2 was demonstrated to be a key regulator of
the protein expression levels of TNF-a, IL-1b, and IFN-g, and
MK2 knockout mice had a significantly reduced inflamma-
tory response in the skin to oxazolone compared with wild-
type mice. Taken together, our results suggest a key role of
MK2 in skin inflammation and identify MK2 as a possible
target in at least Th1-dominated inflammatory skin diseases.
MATERIALS AND METHODS
Mice
Control C57BL/6 mice were purchased from Taconic Europe (Ry,
Denmark). Mice homozygotes for the mutant MK2 knockout allele
have previously been described (Kotlyarov et al., 1999) and were
back crossed to the C57BL/6 strain for more than 10 generations. At
the beginning and during the experimental period, the mice were
investigated by western blotting using total MK2 antibody. Total
MK2 was not detected in the MK2 knockout mice. All mice used in
this study were male and 7–9 weeks of age when experiments were
initiated. The animals were kept in animal facilities that maintained
a temperature of 19–25 1C, and a 12-hour day/night cycle. They were
given access to food and water ad libitum. All experiments were
approved by the Committee for Animal Experiments in Denmark.
Oxazolone-induced murine allergic contact dermatitis
4-Ethoxymethylene-2-phenyl-2-oxazolin-5-one (oxazolone) was
purchased from Sigma-Aldrich (St Louis. MO). Oxazolone was
dissolved in acetone. For every experiment performed a freshly made
solution was used.
Control C57BL/6 mice and MK2 knockout mice were sensitized
with 1.5% oxazolone by application to the clipped abdomen (100 ml)
7 days before challenge with 0.1, 0.5, or 1.5% oxazolone at the ears
(20 ml per ear) as previously described (Webb et al., 1998; Ottosen
et al., 2003; Petersen, 2006). Before challenge (0 hour), the ear
thickness was measured and again post-challenge at the times
indicated, using a Mitutyo digimatic indicator. For determination of
the effect of SB202190, 1mg per ear diluted in acetone was supplied
to sensitized wild-type mice 30minutes before challenge. Similar
concentrations has been used in other studies (Bachelor et al., 2005).
Histology
Skin samples were fixed in 4% formaldehyde, embedded in paraffin,
and processed for histological analysis. Sections were cut at 4 mm,
mounted onto slides, and stained with hematoxylin and eosin
according to the standard procedures.
Isolation of total protein
At the end of the experiments, mice were killed by cervical dislocation.
Ears were clipped off and immediately placed in liquid nitrogen.
Homogenization was carried out by using a TissueLyser from Qiagen
(Haan, Germany), 1 cell lysis buffer (20nM Tris-base (pH 7.5),
150mM NaCl, 1mM EDTA, 1mM EGTA, 1% Triton-X-100, 2.5mM
sodium pyrophosphate, 1mM b-glycerol phosphate, 1mM Na3VO4,
1mgml1 leupeptin, and 1mM phenylmethylsulphonyl fluoride) was
added. The homogenization was carried out over 2 2minutes. The
samples were left on ice for 10minutes. The samples were sonicated
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5 10 seconds and again left on ice for 10minutes, before they were
centrifuged at 10,000 g for 10minutes at 4 1C. The supernatant
constitutes the total whole-cell protein extract.
Western blotting analysis
Equal amounts of whole-cell protein extracts (determined by
Bradford) were separated by SDS-PAGE and blotted onto nitrocellu-
lose membranes. Membranes were incubated with either anti-
phospho-p38, -phospho-MK2 (Thr334), -MK2 (Cell Signalling
Technology, Beverly, MA), or -b-actin (Sigma-Aldrich) and detected
with horseradish peroxidase-conjugated anti-rabbit or anti-goat
antibodies (Dako, Glostrup, Denmark) in a standard ECL reaction
(Cell Signalling Technology). A Biotinylated Protein Ladder Mole-
cular Weight Marker (Cell Signalling Technology) was used for
estimation of protein size.
Kinase assays
The p38 MAPK activity was determined by using a nonradioactive
p38 MAP Kinase Assay Kit (Cell Signalling Technology) according to
the manufacturer’s instructions and as previously described (Johan-
sen et al., 2005). Briefly, 200mg of cell lysate was incubated with
20 ml of immobilized phospho-p38 primary antibody overnight at
4 1C. The immunocomplexes were isolated and then washed twice
with 1 cell lysis buffer and twice with 1 kinase buffer (25mM
Tris (pH 7.5), 5mM b-glycerol phosphate, 2mM DTT, 0.1mM
NA3VO4, and 10mM MgCl2). The pellet was suspended in 1
kinase buffer supplemented with 200mM adenosine 5’-triphosphate
solution and 2mg of ATF2 fusion protein and incubated for
30minutes at 30 1C. The reaction was terminated with 25 ml 3
SDS sample buffer and boiled for 5minutes. Sample (25 ml) was
loaded on SDS-PAGE gel (8–16%).
Myeloperoxidase assay
In separate experiments, a 4mm punch biopsy was taken from the
mouse ear 24 hours after oxazolone challenge and immediately
placed in liquid nitrogen. To determine neutrophil infiltration a MPO
assay was carried out as previously described (Ottosen et al., 2003).
Briefly, the biopsies were placed in a tube containing 200 ml 0.5%
hexadecyl trimethyl ammonium bromide (HTAB). The homogeniza-
tion was carried out by using a TissueLyser from Qiagen. The
samples were shaken, incubated at 37 1C for 1 hour, mixed again,
and centrifuged for 5minutes. MPO activity was assayed in the
supernatant in doublets as follows; 20 ml of the supernatant was
added 96-well plates (CM Lab, Denmark) and 100 ml 3,3´,5,5´-
tetramethylbenzidine (TMB) One, ready-to-use substrate from Kem-
En-Tec Diagnostics A/S (Copenhagen, Denmark). After 10minutes
incubation in the dark at room temperature, the reaction was
stopped by adding 100ml 0.2 M H2SO4. Finally, the results were
determined, by an ELISA reader (Laboratory Systems iEMS Reader
MF, Copenhagen, Denmark) at 450 nm.
A standard curve was constructed with polymorphonuclear human
cells obtained from blood from healthy human volunteers. Poly-
morphonuclear human cells were prepared using Polymorphprep
(AXIS-SHIELD PoC AS, Oslo, Norway) according to the manufac-
turer’s instructions. Briefly, the polyprep and anticoagulated whole
blood were centrifuged at 500 g for 30minutes. After centrifugation,
the polymorphonuclear fraction was diluted by adding one volume of
0.45% NaCl solution. The cells were washed and resuspended in
physiological saline. A standard curve using varied numbers of
polymorphonuclear human cells (2.5 105; 1.25 105; 6.25 104;
3.13 104; 1.56 104; 7800; 3900) with a linear relationship was
always observed when measuring MPO in the mice.
ELISA
TNF-a, IL-1b, and IFN-g protein expression levels were measured by
ELISA using 96-well Maxisorb (Invitrogen, Carlsbad, CA) plates, and
the DuoSet ELISA Development System (R&D Systems, Oxon, UK)
according to the manufacturer’s instructions. The wells were
incubated with 100ml diluted capture antibody, 0.8 mgml1 (TNF-
a); and 4 mgml1 (IL-1b/IFN-g), overnight at room temperature. The
next day, the wells were washed 3 with (phosphate-buffered
saline, PBS), containing 0.05% Tween20, before they were blocked
for 1 hour in 300 ml of 1% BSA in PBS containing 0.05% Tween20.
The standards and the samples were diluted in 1% BSA in PBS for the
TNF-a ELISA, or in reagent diluent containing 0.1% BSA, 0.05%
Tween20 in Tris-buffered saline (20mM Trizma base, 150mM NaCl,
(pH 7.2), for the IL-1b and IFN-g ELISA. Equal amounts of protein in
100ml were added to the wells and incubated for 2 hours at room
temperature and left overnight at 4 1C. The next day, the wells were
washed 3 with PBS and then incubated at room temperature for
2 hours with 100ml diluted detection antibody (150 ngml1, TNF-a;
400 ngml1, IL-1b/IFN-g). The wells were washed 3 in PBS
containing 0.05% Tween20 and incubated with 100 ml diluted
streptavidin-horseradish peroxidase (1:200) for 20minutes. The
wells were washed again in PBS containing 0.05% Tween20 and
visualized by adding 100ml of substrate solution (R&D Systems) and
incubated for 20minutes. The reactions were stopped by incubation
with H2SO4. The results were determined, in doublets, by an ELISA
reader (Laboratory Systems iEMS Reader MF) at 450 nm.
RNA isolation
Punch biopsies (4mm) from the mice ears were transferred to 1ml of
80 1C cold RNAlater-ICE (Ambion inc., Austin, TX). Samples were
kept at 80 1C until 24 hours before RNA purification at which time
they were transferred to 20 1C. On RNA purification, biopsies were
removed from RNAlater-ICE and transferred to 175ml of SV RNA
lysis buffer added b-mercaptoethanol (SV Total RNA Isolation
System; Promega, Madison, WI) and homogenized. RNA purifica-
tion, including DNase treatment of the samples was completed
according to the manufacturer’s instructions (SV Total RNA Isolation
System; Promega). The RNA was stored until further use at 80 1C.
Quantitative RT-PCR
For reverse transcription, we used TaqMan reverse transcription
reagents (Applied Biosystems, Foster City, CA). Primers and probes
were purchased from Applied Biosystems. IL-1b mRNA expression
was analyzed using TaqMan 20 Assays-On-Demand expression
assay mix (Mm00434228_m1). The probe was a FAM-labeled MGB
probe with a nonfluorescent quencher. As housekeeping gene, we
used glyceraldehyde-3-phosphate dehydrogenase. Glyceraldehyde-
3-phosphate dehydrogenase mRNA expression was determined by
using TaqMan 20 Assays-On-Demand expression assay mix (assay
ID: Mm99999915_g1). The probe was a FAM-labeled MGB probe
with a nonfluorescent quencher.
PCR mastermix was TaqMan 2 Universal PCR Master Mix, No
AmpErase (Applied Biosystems). Each gene was analyzed in triplicates.
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Real-time PCR machine was a Rotorgene-3000 (Corbett Re-
search, Sydney, Australia). Reactions were run as singleplex.
Relative gene expression levels were determined by using the
relative standard curve method as outlined in User Bulletin no. 2
(ABI Prism 7700 sequencing detection system, Applied Biosystems).
Briefly, a standard curve for each gene was made of threefold serial
dilutions of total RNA from punch biopsies from the ears of the mice.
The curve was then used to calculate relative amounts of target
mRNA in the samples.
Statistical analysis
Statistical analysis for the ear thickness and the MPO activity were as
follows: the data were analyzed using a linear mixed effects model
with treatment, time, and the interaction between the two as fixed
effects. Mouse and ear (within mouse) were included in the model as
random effects. Correlation between measurements on the same ear
was taken into account. The data were transformed when necessary
and results are presented as back-transformed means with 95%
confidence intervals. Statistical analysis of the TNF-a, IL-1b, and
IFN-g protein expression levels obtained from ELISA assays and the
IL-1b mRNA expression were analyzed as two-way analyses of
variance. Results are shown as back-transformed means with 95%
confidence intervals. Values of Po0.05 were considered significant.
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